Skip to content
Save up to 80% Fast & Discrete Delivery
Buproban
Quality products
Fast & Discrete Delivery
Money-back guarantee

Buproban

4 (5 customer reviews)
Delivery: 4-7 business days
Payment
24/7 Support
Active ingredient: Bupropion

Free bonus tablets with every order: 4 on any order, 8 over $112.00, 12 over $222.88, 16 over $334.88

256-bit SSL
Certified pharmacy
Money-back guarantee

Bupropion hydrochloride, the active ingredient of Buproban, is a norepinephrine-dopamine reuptake inhibitor used in treatment plans for depression and smoking cessation. It supports signaling between nerve cells by slowing the reabsorption of norepinephrine and dopamine.

Overview

Buproban contains bupropion hydrochloride, an antidepressant in the norepinephrine-dopamine reuptake inhibitor, or NDRI, class. It is used in treatment plans for depression and smoking cessation.

Therapeutic indications

Buproban is used in treatment plans for depression and smoking cessation. The treatment purpose and schedule are individualized by the prescriber based on medical history, kidney and liver function, concurrent medicines, and prior response to antidepressants.

How it affects the body

Buproban contains bupropion hydrochloride, an antidepressant from the norepinephrine-dopamine reuptake inhibitor, or NDRI, class. Norepinephrine influences alertness and motivation, while dopamine contributes to reward, drive, and concentration. Bupropion increases the availability of both neurotransmitters between nerve cells.

Unlike selective serotonin reuptake inhibitors, bupropion does not primarily act on serotonin. This difference can matter for people who experienced sexual adverse effects, emotional flattening, or fatigue with serotonin-focused antidepressants. It can also feel more activating during the first weeks of treatment.

Bupropion also blocks some nicotinic acetylcholine receptors. That action contributes to its role in smoking-cessation treatment, where it can reduce nicotine craving and lessen withdrawal-related irritability.

Reasons not to use it

Buproban is not for you if you have a seizure disorder, current or prior bulimia or anorexia nervosa, or if you are abruptly stopping alcohol, benzodiazepines, barbiturates, or certain antiseizure medicines. It must not be combined with a monoamine oxidase inhibitor, also called an MAOI.

Other situations requiring individualized assessment include:

  • Bipolar disorder or past mania or hypomania.
  • Uncontrolled high blood pressure.
  • Severe liver impairment.
  • Significant kidney impairment.
  • Traumatic brain injury or a brain tumor.
  • Diabetes treated with insulin or medicines that can cause low blood sugar.
  • Use of medicines known to lower seizure threshold.
  • A history of suicidal thoughts or self-harm.
  • Pregnancy or breastfeeding.

WHO mental-health guidance supports structured assessment of mood symptoms and suicide risk when antidepressant treatment is considered [3].

When this is not for you

Buproban should not be used if you have seizures, current or past bulimia or anorexia, or are suddenly stopping alcohol or certain sedative medicines. Tell your prescriber if you have bipolar disorder, high blood pressure, liver or kidney problems, diabetes, a history of self-harm, or are pregnant or breastfeeding.

Possible side effects

Bupropion hydrochloride can cause dry mouth, nausea, headache, constipation, sweating, tremor, agitation, anxiety, reduced appetite, and insomnia. These effects are often most noticeable during initiation or after a treatment change. They may settle as the body adjusts, though persistent symptoms deserve clinical review. The timing and severity of symptoms vary between patients. A prescriber can assess whether the dose or treatment plan needs adjustment.

Seizure is the key serious risk associated with bupropion. The risk rises when doses are taken too close together, when tablets are altered, or when a person has factors that lower the seizure threshold. The EMA product information for bupropion identifies seizure risk, neuropsychiatric symptoms, and blood-pressure elevation among the safety issues requiring attention [2].

Some people notice a rise in blood pressure. Those with hypertension benefit from baseline and follow-up blood-pressure assessment, especially when bupropion is combined with nicotine replacement therapy.

New agitation, hostility, severe anxiety, racing thoughts, or a major change in behavior need prompt prescriber contact. These symptoms are more relevant during early treatment and after dose changes.

Urgent medical assessment is needed for seizure, facial swelling, hives, severe rash, chest pain, fainting, severe confusion, hallucinations, or thoughts of self-harm. Antidepressant treatment can alter mood and behavior before its intended benefit is fully established, especially in younger adults.

Bupropion may support energy and concentration for some patients. The trade-off is that it can disrupt sleep or intensify nervousness in others.

Formulation

Buproban contains bupropion hydrochloride, an antidepressant in the norepinephrine-dopamine reuptake inhibitor (NDRI) class. It supports nerve-cell signaling by slowing the reabsorption of norepinephrine and dopamine.

Dosage and administration

Buproban is taken by mouth according to an individualized schedule agreed with the prescriber. The amount and frequency depend on the reason for treatment, medical history, kidney and liver function, concurrent medicines, and prior response to antidepressants.

Modified-release bupropion tablets are designed to release the medicine gradually. They must be swallowed whole. Crushing, chewing, or splitting a modified-release tablet can release too much medicine at once and increase adverse-effect and seizure risk.

When bupropion causes insomnia, prescribers often place doses earlier in the day rather than close to bedtime. Do not change timing or frequency without a prescriber’s direction.

Common administration errors include:

  • Taking an extra tablet after forgetting a dose.
  • Using two doses too close together.
  • Crushing or chewing a modified-release tablet.
  • Stopping abruptly after early restlessness without discussing the symptom.
  • Combining treatment with heavy alcohol intake or abrupt alcohol withdrawal.
  • Starting another antidepressant, stimulant, or antibiotic without reviewing interactions.

A consistent routine helps. Some people link the dose to breakfast or another fixed daily activity, reducing the chance of missed doses.

Management of Missed Doses and Overdose Scenarios

If a Buproban dose is missed, skip it and take the next scheduled dose at the usual time. Do not take an additional tablet or shorten the interval between doses. A double dose increases the risk of seizure and other serious adverse effects.

Suspected overdose requires urgent emergency assessment. Symptoms may include vomiting, marked agitation, hallucinations, fast heartbeat, altered consciousness, tremor, seizures, or dangerous heart-rhythm changes. Modified-release products can cause delayed toxicity, so feeling well soon after taking too much does not rule out a serious reaction.

Write down the time a dose was taken if your routine is disrupted. This simple habit prevents accidental repeat dosing later the same day.

Comparison

Practical differences from serotonin-focused antidepressants

Bupropion is often selected when low energy, reduced motivation, concentration problems, or sexual adverse effects are prominent concerns. It may be less suitable when untreated anxiety, panic symptoms, or insomnia are the dominant issue, since stimulation can feel uncomfortable at the start.

A dry mouth is common. Sleep changes can occur.

Treatment approach Main neurotransmitter effect Clinical fit
Bupropion hydrochloride Raises norepinephrine and dopamine activity Depression with low energy or smoking cessation plans
SSRI antidepressants Raises serotonin activity Depression with prominent anxiety or obsessive symptoms
SNRI antidepressants Raises serotonin and norepinephrine activity Depression with anxiety or some chronic pain conditions

Clinical selection is individual. A history of seizures, eating disorders, bipolar disorder, alcohol use, and other medicines can change whether bupropion is appropriate.

The FDA describes bupropion as an antidepressant with uses that depend on the prescribed formulation and treatment goal [1].

Common mistakes

The most preventable Buproban problems come from administration and interaction errors rather than from the medicine’s intended mechanism.

  • Expecting a full antidepressant response in the first few days.
  • Taking tablets late in the day despite emerging insomnia.
  • Crushing, chewing, or splitting modified-release tablets.
  • Doubling the next dose after a missed dose.
  • Using alcohol heavily or stopping heavy alcohol use suddenly.
  • Assuming an antibiotic is automatically compatible with treatment.
  • Ignoring new anxiety, agitation, or a marked mood shift.
  • Continuing treatment through a seizure, severe rash, or suicidal thoughts without urgent assessment.

Caffeine is another small but relevant detail. Bupropion does not directly prohibit coffee, yet high caffeine intake can magnify shakiness, palpitations, and insomnia during the adjustment period.

What doctors say

In clinical practice, prescribers often choose bupropion when depression includes low drive, tiredness, poor concentration, or concerns about sexual adverse effects from serotonin-focused therapy. The aim is not immediate stimulation. The aim is steadier mood, improved function, and a treatment plan the person can continue consistently.

Doctors also watch closely for activation. Difficulty sleeping, irritability, jitteriness, and anxiety may emerge before benefit becomes clear. Adjusting timing, reviewing caffeine intake, or reassessing the treatment plan can be more useful than silently discontinuing therapy.

For smoking cessation, bupropion works best as one element of a plan that includes a quit date and behavioral support. Cochrane evidence has found that bupropion improves long-term smoking abstinence compared with placebo, though it can cause insomnia and dry mouth [4].

Common questions

Can older adults use Buproban?

Older adults can use bupropion when a prescriber judges that the benefits outweigh the risks. Kidney and liver function may decline with age, which can affect how bupropion and its active metabolites are cleared. FDA prescribing information from 2017 advises considering reduced organ function and concurrent medicines when treatment is selected for older patients. Falls, dizziness, blood-pressure changes, insomnia, and interactions with cardiac or neurological medicines deserve attention.

Can alcohol be used while taking Buproban?

Alcohol can increase dizziness, impair judgment, worsen mood symptoms, and raise seizure risk with bupropion. The concern is greater for people who drink heavily, binge drink, or are planning to stop alcohol abruptly. EMA product information from 2023 warns that alcohol-related seizure risk should be considered during bupropion treatment. Avoiding alcohol is the lowest-risk approach, especially early in treatment or when the dose schedule changes.

How soon does Buproban become noticeable?

Some people notice changes in energy, appetite, or sleep within the first one to two weeks. Improvement in depressed mood, motivation, and daily function often takes several weeks of consistent treatment. NICE guidance from 2021 on depression treatment describes antidepressant response as gradual and recommends review of tolerability and progress during the early phase of therapy. A lack of immediate change does not mean the treatment has failed.

Can Buproban be used during pregnancy or breastfeeding?

Pregnancy and breastfeeding require an individualized assessment of maternal mental health, smoking status, prior treatment response, and fetal or infant exposure. Bupropion crosses into breast milk in small amounts, and infant monitoring may be needed if treatment is used while breastfeeding. The FDA's 2017 prescribing information advises weighing potential benefits against potential risks when bupropion is considered during pregnancy. Untreated depression and continued smoking can also carry health consequences, so the decision should be made with the clinician managing pregnancy care.

Does Buproban cause insomnia?

Yes, insomnia is a well-known bupropion adverse effect. Its norepinephrine and dopamine activity can feel activating, especially when treatment starts or when doses are taken later in the day. Cochrane’s 2023 smoking-cessation review identifies insomnia among the common adverse effects reported with bupropion. Earlier dosing may help when approved by the prescriber, while persistent sleep loss calls for treatment review.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in.) and its contents cannot be seen.

Customer Feedback on Buproban

Ben, 37
Minneapolis
After the first few weeks
Verified
Rating: 5 out of 5
I used Buproban as part of my smoking-cessation plan. The cravings became less intrusive after the first few weeks, and I made it through my usual stressful commute without buying cigarettes. I felt more in control of the routine.
Oct 12, 2026
Harry, 37
Boston
Several weeks; by the second month
Verified
Rating: 5 out of 5
I took Buproban for low mood and lack of motivation. After several weeks, getting through work tasks felt less overwhelming and I started exercising again after work. The change was gradual, but it was clear by the second month.
Oct 20, 2026
Mark, 41
Milwaukee
About three weeks
Verified
Rating: 3 out of 5
Buproban helped my concentration and I had fewer cigarette cravings after about three weeks. Sleep was rough at first because I was taking it too late in the day. Once my prescriber reviewed the timing, the insomnia became more manageable.
Oct 28, 2026
David, 64
Nashville
Verified
Rating: 4 out of 5
I used Buproban during a planned quit attempt. I had been smoking for decades, and the constant urge eased enough for me to stick with my quit date. I appreciated that the progress felt steady instead of dramatic.
Nov 5, 2026
James K., 35
Portland
After the first couple of weeks
Verified
Rating: 3 out of 5
I noticed more energy after the first couple of weeks, but I also felt tense and restless in the evenings. The benefit was real, yet the sleep disruption made the treatment hard for me to continue. I discussed other options with my prescriber.
Nov 7, 2026

Sources

  1. FDA (2017). Wellbutrin XL: Prescribing Information.
  2. European Medicines Agency (2023). Zyban: Product Information.
  3. World Health Organization (2023). Mental Health Gap Action Programme Intervention Guide, Version 2.0.
  4. Cochrane (2023). Antidepressants for Smoking Cessation.
Get our free app Shop faster and track your orders 4.0 · 266 reviews Install